Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
893.00
-4.00 (-0.45%)
Nov 18, 2026, 10:20 AM JST

TYO:4570 Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,0821,004969816794647
Revenue Growth
7.13%3.61%18.75%2.77%22.72%7.47%
Gross Profit
780706634516526376
Operating Income
33728120911052-122
Net Income
374329249186-289-258
Earnings Per Share
40.1635.3326.7419.97-31.03-27.70
EPS Growth
17.24%32.13%33.87%---

Revenue by Segment

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '25 Mar '24 Mar '23 Mar '22
Antibody Related Business
1,002964.37812.85790.6637.47
Cosmetics Related
2.685.163.854.0213.35
Total
1,005969.53816.7794.62647.58

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
987989825734614508
Total Debt
169176204235234233
Net Cash (Debt)
818813621499380275
Net Cash Growth
6.79%30.92%24.45%31.32%38.18%-46.50%
Net Cash Per Share
87.8387.2966.6853.5840.8029.53

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
30130118313326-93
Capital Expenditures
-14-33-59-16--
Free Cash Flow
28726812411726-93
Free Cash Flow Growth
25.88%116.13%5.98%350.00%--

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
72.09%70.32%65.43%63.23%66.25%58.11%
Operating Margin
31.15%27.99%21.57%13.48%6.55%-18.86%
Pretax Margin
31.98%29.98%21.67%15.20%-35.26%-38.64%
Profit Margin
34.57%32.77%25.70%22.79%-36.40%-39.88%
FCF Margin
26.52%26.69%12.80%14.34%3.28%-14.37%

Dividends

Fiscal Year
CurrentFY 2026
Period EndingNov '26 Mar '26
Dividend Per Share
7.5006.000
Dividend Per Share Growth
25.00%-
Dividend Yield
0.84%0.45%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
22.2437.9917.9526.49--
P/FCF Ratio
29.1146.6436.0542.11145.79-
PS Ratio
7.7212.454.616.044.774.71